Paired Ends: Akiva Mozes, Ziv Kop, Heidi Melin | GenomeWeb

The agricultural genomics firm Evogene has appointed Akiva Mozes and Ziv Kop to serve on its board of directors.

Mozes is chairman of Bazan Group's Oil Refinery, a member of the board of directors of Strauss Group, and he formerly was president and CEO of Israel Chemicals.

Kop is the founder and CEO of Go Capital, and he formerly was managing partner at Glenrock Israel and CEO of POC management consulting.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."